Nishant Mohan

1.4k total citations
42 papers, 897 citations indexed

About

Nishant Mohan is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Nishant Mohan has authored 42 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Molecular Biology and 16 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Nishant Mohan's work include HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). Nishant Mohan is often cited by papers focused on HER2/EGFR in Cancer Research (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). Nishant Mohan collaborates with scholars based in United States, Switzerland and Russia. Nishant Mohan's co-authors include Wen Jin Wu, Yukinori Endo, Yi Shen, Milos Dokmanovic, M. Khair ElZarrad, Naren L. Banik, Swapan K. Ray, Dianne S. Hirsch, Partha Mukhopadhyay and Pál Pacher and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Nishant Mohan

39 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nishant Mohan United States 18 441 291 263 206 83 42 897
Juha Näpänkangas Finland 16 367 0.8× 305 1.0× 208 0.8× 96 0.5× 29 0.3× 35 1.0k
Karla Esbona United States 13 238 0.5× 327 1.1× 117 0.4× 83 0.4× 116 1.4× 20 797
Fei Hua United States 20 156 0.4× 679 2.3× 304 1.2× 133 0.6× 27 0.3× 58 1.4k
Oliver Pötz Germany 16 113 0.3× 486 1.7× 86 0.3× 90 0.4× 101 1.2× 37 883
Su Wang China 14 141 0.3× 441 1.5× 385 1.5× 45 0.2× 45 0.5× 51 990
Klaus Wielckens Germany 21 560 1.3× 702 2.4× 214 0.8× 46 0.2× 47 0.6× 51 1.4k
Deshun Lu United States 16 142 0.3× 310 1.1× 120 0.5× 41 0.2× 56 0.7× 23 1.1k
Sudeep Chandra United States 13 155 0.4× 242 0.8× 63 0.2× 179 0.9× 21 0.3× 23 672
Xiaomeng Shen United States 18 96 0.2× 462 1.6× 82 0.3× 91 0.4× 33 0.4× 31 754
Begoña Lavín United Kingdom 16 49 0.1× 258 0.9× 298 1.1× 218 1.1× 71 0.9× 32 907

Countries citing papers authored by Nishant Mohan

Since Specialization
Citations

This map shows the geographic impact of Nishant Mohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nishant Mohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nishant Mohan more than expected).

Fields of papers citing papers by Nishant Mohan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nishant Mohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nishant Mohan. The network helps show where Nishant Mohan may publish in the future.

Co-authorship network of co-authors of Nishant Mohan

This figure shows the co-authorship network connecting the top 25 collaborators of Nishant Mohan. A scholar is included among the top collaborators of Nishant Mohan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nishant Mohan. Nishant Mohan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leng, Theodore, Ella H. Leung, Srinivas Mukkamala, et al.. (2025). Longitudinal Validation of the Artificial Intelligence Algorithm in Home OCT for Age-Related Macular Degeneration—Report 3. Ophthalmology Science. 6(2). 100907–100907.
2.
Heier, Jeffrey S., Nancy M. Holekamp, Miguel Busquets, et al.. (2025). Pivotal Trial Validating Usability and Visualization Performance of Home OCT in Neovascular Age-Related Macular Degeneration: Report 1. Ophthalmology Science. 5(5). 100772–100772. 2 indexed citations
3.
Mohan, Nishant, Hanjing Peng, Yi Shen, et al.. (2024). Structural and functional characterization of IgG- and non-IgG-based T-cell-engaging bispecific antibodies. Frontiers in Immunology. 15. 1376096–1376096. 4 indexed citations
4.
Heier, Jeffrey S., Nancy M. Holekamp, Miguel Busquets, et al.. (2024). Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2—Artificial Intelligence Analytics. SHILAP Revista de lepidopterología. 5(2). 100662–100662. 5 indexed citations
5.
Endo, Yukinori, Brady T. Hickerson, Natalia A. Ilyushina, et al.. (2022). Identification of a pharmacological approach to reduce ACE2 expression and development of an in vitro COVID-19 viral entry model. Journal of Virus Eradication. 8(4). 100307–100307. 4 indexed citations
6.
Mohan, Nishant, Yi Shen, Yukinori Endo, et al.. (2022). Comparative Characterization of Different Molecular Formats of Bispecific Antibodies Targeting EGFR and PD-L1. Pharmaceutics. 14(7). 1381–1381. 2 indexed citations
7.
Zhao, Jun, Nishant Mohan, Ruth Nussinov, Buyong Ma, & Wen Jin Wu. (2021). Trastuzumab Blocks the Receiver Function of HER2 Leading to the Population Shifts of HER2-Containing Homodimers and Heterodimers. Antibodies. 10(1). 7–7. 15 indexed citations
8.
Endo, Yukinori, Sarah Lyon, Yi Shen, Nishant Mohan, & Wen Jin Wu. (2019). Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cells. Scientific Reports. 9(1). 16383–16383. 8 indexed citations
9.
Endo, Yukinori, et al.. (2018). T-DM1-resistant cells gain high invasive activity via EGFR and integrin cooperated pathways. mAbs. 10(7). 1–15. 28 indexed citations
10.
Dokmanovic, Milos, Kathryn E. King, Nishant Mohan, Yukinori Endo, & Wen Jin Wu. (2017). Cardiotoxicity of ErbB2-targeted therapies and its impact on drug development, a spotlight on trastuzumab. Expert Opinion on Drug Metabolism & Toxicology. 13(7). 755–766. 18 indexed citations
11.
Mohan, Nishant, Yi Shen, Yukinori Endo, M. Khair ElZarrad, & Wen Jin Wu. (2016). Trastuzumab, but Not Pertuzumab, Dysregulates HER2 Signaling to Mediate Inhibition of Autophagy and Increase in Reactive Oxygen Species Production in Human Cardiomyocytes. Molecular Cancer Therapeutics. 15(6). 1321–1331. 114 indexed citations
12.
Yan, Haoheng, Yukinori Endo, Yi Shen, et al.. (2015). Ado-Trastuzumab Emtansine Targets Hepatocytes Via Human Epidermal Growth Factor Receptor 2 to Induce Hepatotoxicity. Molecular Cancer Therapeutics. 15(3). 480–490. 52 indexed citations
13.
Mohan, Nishant & Wen Jin Wu. (2015). Trastuzumab is not a tyrosine kinase inhibitor. Nature Reviews Cardiology. 12(11). 669–669. 4 indexed citations
14.
Hirsch, Dianne S., Yi Shen, Milos Dokmanovic, et al.. (2014). Insulin activation of vacuolar protein sorting 34 mediates localized phosphatidylinositol 3-phosphate production at lamellipodia and activation of mTOR/S6K1. Cellular Signalling. 26(6). 1258–1268. 16 indexed citations
15.
Mohan, Nishant, Mrinmay Chakrabarti, Naren L. Banik, & Swapan K. Ray. (2013). Combination of LC3 shRNA Plasmid Transfection and Genistein Treatment Inhibited Autophagy and Increased Apoptosis in Malignant Neuroblastoma in Cell Culture and Animal Models. PLoS ONE. 8(10). e78958–e78958. 29 indexed citations
16.
ElZarrad, M. Khair, Partha Mukhopadhyay, Nishant Mohan, et al.. (2013). Trastuzumab Alters the Expression of Genes Essential for Cardiac Function and Induces Ultrastructural Changes of Cardiomyocytes in Mice. PLoS ONE. 8(11). e79543–e79543. 106 indexed citations
17.
Mohan, Nishant, Naren L. Banik, & Swapan K. Ray. (2011). Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells. Neuroscience Letters. 502(1). 24–29. 39 indexed citations
18.
Mohan, Nishant & Benjamin J. Vakoc. (2011). Principal-component-analysis-based estimation of blood flow velocities using optical coherence tomography intensity signals. Optics Letters. 36(11). 2068–2068. 13 indexed citations
19.
Mohan, Nishant, Surajit Karmakar, Subhasree Roy Choudhury, Naren L. Banik, & Swapan K. Ray. (2009). Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Brain Research. 1283. 155–166. 8 indexed citations
20.
Mohan, Nishant, Olga Minaeva, Gregory Goltsman, et al.. (2008). Photon-counting optical coherence-domain reflectometry using superconducting single-photon detectors. Optics Express. 16(22). 18118–18118. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026